Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-25 @ 2:49 AM
NCT ID:
NCT01885533
Eligibility Criteria:
Inclusion Criteria:
* Out-patients 18 years of age or over, who have given written informed consent to participate in the study
* Diagnosed with Graves' disease
* Received radioiodine for treatment of Graves' disease
* Had a minimum of 12 months follow-up after RI
* Most recent RI dose 5 years ago or less at the time of enrollment
Exclusion Criteria:
* Patients unable to give informed consent
* Age 17 years or younger
* Cause of thyrotoxicosis other than Graves' disease
* Patients who have had more than one dose of radioiodine can only be included in the study once, using data pertaining to their most recent treatment episode.
* Patients who might not adequately understand verbal explanations or written information given in English, or who have special communication needs
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01885533
Study Brief:
Protocol Section:
NCT01885533